Advanced Pharma Inc. has recalled 100 syringes of Fentanyl Citrate USP (5 mcg in 0.9% Sodium Chloride USP, 0.5 mL) because the medication is subpotent, meaning the drug concentration is lower than what is indicated on the label. This recall affects 100 prefilled syringes that were distributed to a single medical center in Fort Worth, Texas. Because the drug is less powerful than expected, patients may not receive the intended therapeutic dose, which can lead to inadequate pain management. Patients who received this medication should contact their healthcare provider or pharmacist.
The drug's concentration is lower than labeled, which may result in patients receiving a lower dose than prescribed, leading to ineffective treatment and uncontrolled pain.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.